Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Int J Qual Health Care ; 33(Supplement_1): 4-10, 2021 Jan 12.
Artículo en Inglés | MEDLINE | ID: mdl-32780821

RESUMEN

BACKGROUND: This paper describes a rapid response project from the Chartered Institute of Ergonomics & Human Factors (CIEHF) to support the design, development, usability testing and operation of new ventilators as part of the UK response during the COVID-19 pandemic. METHOD: A five-step approach was taken to (1) assess the COVID-19 situation and decide to formulate a response; (2) mobilise and coordinate Human Factors/Ergonomics (HFE) specialists; (3) ideate, with HFE specialists collaborating to identify, analyse the issues and opportunities, and develop strategies, plans and processes; (4) generate outputs and solutions; and (5) respond to the COVID-19 situation via targeted support and guidance. RESULTS: The response for the rapidly manufactured ventilator systems (RMVS) has been used to influence both strategy and practice to address concerns about changing safety standards and the detailed design procedure with RMVS manufacturers. CONCLUSION: The documents are part of a wider collection of HFE advice which is available on the CIEHF COVID-19 website (https://covid19.ergonomics.org.uk/).


Asunto(s)
COVID-19 , Ergonomía/métodos , Ventiladores Mecánicos/normas , Diseño de Equipo/métodos , Diseño de Equipo/normas , Ergonomía/normas , Humanos , Seguridad del Paciente/normas , Reino Unido
2.
FEBS J ; 280(18): 4512-21, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23809212

RESUMEN

The use of hyperoxia for critically ill patients is associated with adverse impacts resulting in lung injury accompanied by inflammation. The aim of this study was to evaluate aspects of mechanisms that contribute to hyperoxia-induced disruption of the epithelial permeability barrier, and also the protective effects of the antioxidants α-tocopherol and ascorbate. 16HBE14o- cells were cultured as monolayers at an air-liquid interface for 6 days, after which transepithelial electrical resistance reached 251.2 ± 4.1 Ω.cm(2) (mean ± standard error of the mean). They were then exposed for 24 h to normoxia (21% O2, 5% CO2), hyperoxia (95% O2, 5% CO2), hyperoxia with 10(-7) M α-tocopherol, hyperoxia with 10(-7) M ascorbate, hyperoxia with 10(-6) M ascorbate, and hyperoxia with a combination of α-tocopherol and ascorbate (10(-7) M and 10(-6) M, respectively). Significant reductions (P < 0.05) in transepithelial electrical resistance seen after hyperoxia (with or without antioxidants) were associated with reductions in the levels of zona occludens-1 (ZO-1) observed by immunohistochemistry, and downregulation of ZO-1 expression (P < 0.01) as compared with normoxia. In contrast, the expression levels of interleukin (IL)-8, IL-6 and tumour necrosis factor-α (TNF-α) were increased after hyperoxia (P < 0.01), and marked increases in the levels of these cytokines (ELISA) were seen in the medium (P < 0.001) as compared with normoxia. The antioxidant vitamins E and C had a partial protective effect against the hyperoxia-induced reduction in ZO-1 levels and the increase in levels of the proinflammatory cytokines IL-8, IL-6, and TNF-α. In conclusion, hyperoxia-induced epithelial disruption is associated with tight junction weakening, and induction of a proinflammatory environment.


Asunto(s)
Antioxidantes/farmacología , Ácido Ascórbico/farmacología , Células Epiteliales/efectos de los fármacos , Hiperoxia/metabolismo , Oxígeno/farmacología , Vitamina E/farmacología , Bronquios/citología , Bronquios/efectos de los fármacos , Bronquios/metabolismo , Membrana Celular/efectos de los fármacos , Membrana Celular/metabolismo , Permeabilidad de la Membrana Celular/efectos de los fármacos , Impedancia Eléctrica , Células Epiteliales/citología , Células Epiteliales/metabolismo , Expresión Génica/efectos de los fármacos , Humanos , Hiperoxia/genética , Hiperoxia/patología , Interleucina-6/agonistas , Interleucina-6/genética , Interleucina-6/metabolismo , Interleucina-8/agonistas , Interleucina-8/genética , Interleucina-8/metabolismo , Mucosa Respiratoria/citología , Mucosa Respiratoria/efectos de los fármacos , Mucosa Respiratoria/metabolismo , Uniones Estrechas/efectos de los fármacos , Uniones Estrechas/metabolismo , Factor de Necrosis Tumoral alfa/agonistas , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo , Proteína de la Zonula Occludens-1/antagonistas & inhibidores , Proteína de la Zonula Occludens-1/genética , Proteína de la Zonula Occludens-1/metabolismo
3.
Biochem Biophys Res Commun ; 429(3-4): 191-6, 2012 Dec 14.
Artículo en Inglés | MEDLINE | ID: mdl-23142230

RESUMEN

Although elevated oxygen fraction is used in intensive care units around the world, pathological changes in pulmonary tissue have been shown to occur with prolonged exposure to hyperoxia. In this work a bovine bronchus culture model has been successfully used to evaluate the effects of hyperoxia on ciliated epithelium in vitro. Samples were cultured using an air interface method and exposed to normoxia, 21% O(2) or hyperoxia, 95% O(2). Cilial coverage was assessed using scanning electron microscopy (SEM). Tissue damage (lactate dehydrogenase, LDH, in the medium), lipid peroxidation (thiobarbituric acid reactive substances, TBARS), DNA damage (comet assay), protein oxidation (OxyBlot kit) and antioxidant status (total glutathione) were used to assess whether the hyperoxia caused significant oxidative stress. Hyperoxia caused a time-dependent decline (t(½)=3.4d compared to 37.1d under normoxia) in cilial coverage (P<0.0001). This was associated with a significant increase in the number of cells (2.80 ± 0.27 × 10(6) compared to 1.97 ± 0.23 × 10(6)ml(-1) after 6d), many apparently intact, in the medium (P<0.05); LDH release (1.06 ± 0.29 compared to 0.83 ± 0.36 µmol min(-1)g(-1) after 6d; P<0.001); lipid peroxidation (352 ± 16 versus 247 ± 11 µmol MDA g(-1) for hyperoxia and normoxia, respectively); % tail DNA (18.7 ± 2.2 versus 11.1 ± 1.5); protein carbonyls (P<0.05); and total glutathione (229 ± 20 µmol g(-1) versus 189 ± 15 µmol g(-1)). Vitamins E (10(-7)M) and C (10(-6) or 10(-7)M) alone or in combination (10(-7)M and 10(-6)M, respectively) had a significant protective effect on the hyperoxia-induced reduction in percentage cilial coverage (P<0.05). In conclusion, hyperoxia caused damage to cultured bovine bronchial epithelium and denudation of cilia. The antioxidant vitamins E and C significantly protected against hyperoxia-induced cilia loss.


Asunto(s)
Antioxidantes/farmacología , Ácido Ascórbico/farmacología , Citoprotección , Hiperoxia/patología , Estrés Oxidativo/efectos de los fármacos , Mucosa Respiratoria/efectos de los fármacos , Mucosa Respiratoria/patología , Vitamina E/farmacología , Animales , Bronquios/efectos de los fármacos , Bronquios/enzimología , Bronquios/patología , Bovinos , Células Cultivadas , Cilios/efectos de los fármacos , Cilios/patología , Daño del ADN , L-Lactato Deshidrogenasa/metabolismo , Peroxidación de Lípido , Mucosa Respiratoria/enzimología
5.
Ultrastruct Pathol ; 31(5): 339-46, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17963183

RESUMEN

The effect of hyperoxia on ciliary abundance in cultured explants of adult human bronchus was investigated. Bronchus samples were removed during surgery from patients receiving pneumonectomy or lobectomy for malignancy. Part or all of each of these samples was used for measurement of cilial abundance by scanning electron microscopy (SEM); in many cases the remainder was subdivided and cultured at 37 degrees C in DMEM medium, maintaining an air interface at the ciliated surface of each segment. Cultured segments were exposed to normoxia or hyperoxia (95% O(2)), and a segment was removed every other day for quantification of cilial abundance by SEM. There was a significant inverse relationship between smoking history and abundance (p = .017; ANOVA); mean values for nonsmokers, ex-smokers, and smokers were 98.2% (n = 6), 97.0% (n = 17), and 84.02% (n = 9), respectively. There was some loss of cilia on explant segments cultured under normoxia, but the rate of loss from segments cultured under hyperoxia was significantly greater (W test, p = .00011); rate constants (means +/- SE) for cilial loss of 0.0208 +/- 0.0044 day(-1) and 0.0880 +/- 0.0179 day(-1) were found for explant segments exposed to 21 and 95% O2, respectively (n = 20).


Asunto(s)
Bronquios/efectos de los fármacos , Cilios/efectos de los fármacos , Hiperoxia/inducido químicamente , Oxígeno/administración & dosificación , Anciano , Anciano de 80 o más Años , Bronquios/patología , Cilios/ultraestructura , Femenino , Humanos , Hiperoxia/patología , Masculino , Microscopía Electrónica de Rastreo , Persona de Mediana Edad , Técnicas de Cultivo de Órganos
6.
Intensive Care Med ; 28(7): 884-90, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12122526

RESUMEN

OBJECTIVE: To determine whether an infusion of dopexamine for up to 7 days has an effect on gastrointestinal (GIT) absorption and permeability, renal function or organ dysfunction in the critically ill. DESIGN AND SETTING: Prospective, randomised controlled clinical trial in two general adult intensive care units. PATIENTS: 102 critically ill adult patients predicted to require organ support for at least 4 days. INTERVENTIONS: After resuscitation patients were randomly assigned to receive an infusion of up to 2 mcg/kg/min [corrected] per minute of dopexamine or control. MEASUREMENTS AND RESULTS: GIT absorption and permeability were measured using the ratio of absorbed rhamnose to 3- O-methyl- D-glucose and the ratio of lactulose to rhamnose on days 1, 4 and 7. Creatinine clearance was measured concurrently. Daily Sequential Organ Failure Assessment scores were calculated. Fifty-two patients received dopexamine. No significant difference between the two groups emerged on any of the measured parameters during the study period. CONCLUSIONS: No benefit was seen from a prolonged infusion of dopexamine in this group of critically ill patients in terms of GIT absorption and permeability, creatinine clearance or organ dysfunction.


Asunto(s)
Enfermedad Crítica , Sistema Digestivo/efectos de los fármacos , Dopamina/análogos & derivados , Dopamina/administración & dosificación , Riñón/efectos de los fármacos , Creatinina/orina , Sistema Digestivo/fisiopatología , Dopamina/farmacología , Humanos , Absorción Intestinal , Riñón/fisiopatología , Persona de Mediana Edad , Permeabilidad , Resultado del Tratamiento , Reino Unido
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...